PERTURBED CELL-GROWTH AND ARA-C PHARMACOLOGY IN ACUTE MYELOID-LEUKEMIA (AML) AT DIAGNOSIS AND AT RELAPSE

被引：0
|
作者：
KARP, JE [1 ]
DONEHOWER, RC [1 ]
DOLE, GB [1 ]
BURKE, PJ [1 ]
机构：
[1] JOHNS HOPKINS UNIV HOSP,CTR ONCOL,BALTIMORE,MD 21205
来源：
CELL AND TISSUE KINETICS | 1987年 / 20卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [1] PERTURBED CELL-GROWTH, INTRACELLULAR ARA-C PHARMACOLOGY AND CLINICAL-RESPONSE IN ADULTS WITH ACUTE MYELOID-LEUKEMIA
    KARP, JE
    DONEHOWER, RC
    DOLE, GB
    BURKE, PJ
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 351 - 351
  • [2] CLINICAL-PHARMACOLOGY OF INTERMEDIATE DOSE ARA-C (ID ARA-C) IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA IN RELAPSE
    VANPROOYEN, HC
    DEKKER, AW
    PUNT, K
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (02) : 355 - 356
  • [3] INVIVO GROWTH AND ARA-C PHARMACOLOGICAL DETERMINANTS OF CLINICAL-RESPONSE IN ACUTE MYELOID-LEUKEMIA (AML)
    KARP, JE
    DONEHOWER, RC
    DOLE, GB
    ENTERLINE, J
    BURKE, PJ
    CELL AND TISSUE KINETICS, 1988, 21 (01): : 61 - 62
  • [4] SMALL DOSES OF ARA-C IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA - DIFFERENTIATION OF MYELOID-LEUKEMIA CELLS
    HOUSSET, M
    DANIEL, MT
    DEGOS, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (01) : 125 - 129
  • [5] ARA-C AND AMSA FOR TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA
    JAGER, U
    LECHNER, K
    SCHWARZINGER, I
    BETTELHEIM, P
    BOGNAR, H
    GEISSLER, K
    HAAS, O
    HINTERBERGER, W
    KOS, M
    LEITHA, T
    NEUMANN, E
    PANZER, S
    POLLAK, C
    BLUT, 1986, 53 (03): : 145 - 145
  • [6] LOW-DOSE ARA-C(LODAC) IN ACUTE MYELOID-LEUKEMIA
    AMADORI, S
    PETTI, MC
    AVVISATI, G
    SIKOGLOU, N
    MANDELLI, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 185 - 185
  • [7] ARA-C AND AMSA IN THE THERAPY OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA
    JAGER, U
    WIENER KLINISCHE WOCHENSCHRIFT, 1986, 98 (17) : 589 - 589
  • [8] LOW-DOSE CYTARABINE (ARA-C) IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    MUFTI, GJ
    OSCIER, DG
    HAMBLIN, TJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (03) : 571 - 571
  • [9] PRONOSTIC VALUE OF INVITRO UPTAKE AND RETENTION OF CYTOSINE-ARABINOSIDE (ARA-C) IN ACUTE MYELOID-LEUKEMIA (AML)
    MARIE, JP
    ZITTOU, R
    DELANIAN, S
    SUBERVILLE, AM
    THEVENIN, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 208 - 208
  • [10] ENZYMATIC DETERMINANTS OF RESPONSE TO CYTOSINE-ARABINOSIDE (ARA-C) IN PATIENTS (PTS) WITH ACUTE MYELOID-LEUKEMIA (AML)
    RIVA, CM
    DESOUZA, G
    FERRIER, F
    MERLIN, M
    TUBIANA, N
    LEJEUNE, C
    GASTAUT, JA
    BARRA, Y
    CANO, JP
    CARCASSONNE, Y
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 502 - 502
12345